Literature DB >> 21073646

The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials.

L Wu1, P Li, J Wu, Y Cao, F Gao.   

Abstract

AIM: The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis (UC) was systematically evaluated.
METHOD: Original studies in any language were searched from PubMed and Embase. Meta-analysis of prospective studies that compared chromoendoscopy with histological diagnosis was carried out. Sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated for each study and pooled together; summary receiver operating characteristic (ROC) and subgroup analyses were performed, while the quality of the study and heterogeneity were assessed.
RESULTS: Six randomized controlled trials were included, which used methylene blue or indigo carmine dye spray. The meta-analysis demonstrated a pooled sensitivity of 83.3% (95% confidence interval (CI), 35.9-99.6%), specificity of 91.3% (95% CI, 43.8-100%), and DOR of 17.544 (95% CI, 1.245-247.14). Subgroup analyses revealed that both the methylene blue dye spray subgroup and the unspecified endoscopist subgroup include the same studies, and their pooled sensitivity and specificity were 0.737 and 0.917, respectively. The other subgroup, which used indigo carmine dye spray, had overall higher sensitivity (0.930) and lower specificity (0.910).
CONCLUSION: Chromoendoscopy has medium to high sensitivity and a high diagnostic accuracy for dysplastic lesions in UC.
© 2010 The Authors. Colorectal Disease © 2010 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21073646     DOI: 10.1111/j.1463-1318.2010.02505.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  24 in total

1.  Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.

Authors:  Gauree Gupta Konijeti; Mark G Shrime; Ashwin N Ananthakrishnan; Andrew T Chan
Journal:  Gastrointest Endosc       Date:  2013-11-18       Impact factor: 9.427

Review 2.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

3.  Quality indicators for colonoscopy.

Authors:  Douglas K Rex; Philip S Schoenfeld; Jonathan Cohen; Irving M Pike; Douglas G Adler; M Brian Fennerty; John G Lieb; Walter G Park; Maged K Rizk; Mandeep S Sawhney; Nicholas J Shaheen; Sachin Wani; David S Weinberg
Journal:  Am J Gastroenterol       Date:  2014-12-02       Impact factor: 10.864

Review 4.  New endoscopic imaging techniques in surveillance of inflammatory bowel disease.

Authors:  Tommaso Gabbani; Natalia Manetti; Andrea Giovanni Bonanomi; Antonio Luca Annese; Vito Annese
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

Review 5.  Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.

Authors:  Samir A Shah; David T Rubin; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2014-09

Review 6.  Light and sound - emerging imaging techniques for inflammatory bowel disease.

Authors:  Ferdinand Knieling; Maximilian J Waldner
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

7.  Endoscopic imaging.

Authors:  Vani J A Konda
Journal:  Curr Treat Options Gastroenterol       Date:  2015-06

Review 8.  Ulcerative Colitis: Update on Medical Management.

Authors:  Heba N Iskandar; Tanvi Dhere; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2015-11

Review 9.  Colorectal Cancer in Inflammatory Bowel Disease.

Authors:  Ryan W Stidham; Peter D R Higgins
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

Review 10.  Indications, stains and techniques in chromoendoscopy.

Authors:  P J Trivedi; B Braden
Journal:  QJM       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.